The weight loss drug Wegovy has garnered significant attention in New Zealand, with over 18,000 prescriptions issued since its launch in July 2023. While the drug...
Recent investigations into the effects of the weight-loss drug Wegovy have revealed a surprising benefit: a reduction in cravings for alcohol. Some patients using this medication...
Recent observations suggest that medications originally designed for weight management, such as Wegovy, could help patients reduce their alcohol consumption. Some individuals using semaglutide, the active...
The recent approval of GLP-1 receptor agonists, including Wegovy and Saxenda, marks a significant development in New Zealand’s fight against obesity. These drugs are now available...
New Zealand has recently made significant strides in combating obesity with the approval of weight loss drugs such as Wegovy and Saxenda. These medications, which belong...
The debate over whether to publicly fund weight loss drugs, such as Wegovy, to combat New Zealand’s obesity crisis has intensified. New Zealand currently ranks third...
The introduction of the weight-loss drug Semaglutide, marketed as Wegovy, has gained traction in New Zealand over the past few months. With its potential to significantly...
Concerns over the rising costs and long-term implications of GLP-1 weight-loss drugs like Mounjaro and Wegovy have prompted many users to reconsider their reliance on these...
The weight loss drug Wegovy, which has received endorsements from various celebrities, is gaining traction as new advertising campaigns roll out across social media platforms. Recent...
